| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5351c62aee4203f2be2944f21a6def2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55511 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 |
| filingDate |
2020-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81c6fac804fd13810c744f051c3504cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3568e099ea3117e41afc7bce155878e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a936710d95567f3862a07f54587c1734
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0eae49ce1c59d61c340e7d855dafbc0e |
| publicationDate |
2020-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020197346-A2 |
| titleOfInvention |
Virus vaccine adjuvant composition containing green tea-derived component |
| abstract |
The present invention relates to a virus vaccine adjuvant composition containing epigallocatechin gallate (EGCG) or a green tea extract as an active ingredient. The adjuvant of the present invention not only exhibits an excellent immunostimulatory effect in immune responses to various viruses, but also has almost no toxicity, and thus is outstandingly safe. In addition, when co-administered with alum, the adjuvant containing the green tea extract or EGCG of the present invention may more strongly enhance the immune response of a vaccine. |
| priorityDate |
2019-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |